About HYCOR BioMedical
HYCOR BioMedical is a company based in Garden Grove (United States) founded in 1981. HYCOR BioMedical has raised $99.57 million across 5 funding rounds. HYCOR BioMedical offers products and services including NOVEOS System, Specific IgE Allergens, and HYTEC Multiple Real-Time PCR Kit. HYCOR BioMedical operates in a competitive market with competitors including Exagen, Kypha, TBG Diagnostics, Lophius Biosciences and SmartHealth, among others.
- Headquarter Garden Grove, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hycor Biomedical Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$99.57 M (USD)
in 5 rounds
-
Latest Funding Round
$20 M (USD), Series D
Dec 29, 2020
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HYCOR BioMedical
HYCOR BioMedical offers a comprehensive portfolio of products and services, including NOVEOS System, Specific IgE Allergens, and HYTEC Multiple Real-Time PCR Kit.
Instrument for allergy blood testing and laboratory efficiency.
Kits for detecting specific IgE allergens in diagnostics.
Kit for multiple real-time PCR applications in molecular diagnostics.
People of HYCOR BioMedical
Unlock access to complete
Funding Insights of HYCOR BioMedical
HYCOR BioMedical has successfully raised a total of $99.57M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $20 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by HYCOR BioMedical
Investment portfolio details for HYCOR BioMedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HYCOR BioMedical
Detailed financials for HYCOR BioMedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hycor Biomedical Comparisons
Peer comparison for HYCOR BioMedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HYCOR BioMedical
HYCOR BioMedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Exagen, Kypha, TBG Diagnostics, Lophius Biosciences and SmartHealth, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
|
|
| Locked | Locked | Locked |
Diagnostic biomarker tests for inflammation and autoimmune diseases are developed.
|
|
| Locked | Locked | Locked |
Molecular diagnostics kits, instruments, and software are developed and manufactured.
|
|
| Locked | Locked | Locked |
T-cell-based diagnostics for infectious and immune diseases are developed.
|
|
| Locked | Locked | Locked |
Precision diagnostics for vascular, metabolic, and oncological diseases are developed.
|
Detailed competitors of HYCOR BioMedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hycor Biomedical
Complete news archive for HYCOR BioMedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HYCOR BioMedical
HYCOR BioMedical was founded in 1981 and raised its 1st funding round 36 years after it was founded.
HYCOR BioMedical is headquartered in Garden Grove, United States. It is registered at Garden Grove, California, United States.
HYCOR BioMedical is a funded company, having raised a total of $99.57M across 5 funding rounds to date.
HYCOR BioMedical was founded in 1981 and is located in Garden Grove, United States. In vitro diagnostic instruments and reagents are developed for autoimmune diseases and allergies. Flagship products include the HYTEC 288 Plus, which is used for allergy and autoimmune antibody testing, and the HYCOR Ultra-Sensitive System, which is applied in ELISA procedures. Operations center on clinical diagnostic tools within the biomedical sector.
HYCOR BioMedical's top competitors include Exagen, SmartHealth and Lophius Biosciences.
HYCOR BioMedical offers NOVEOS System, Specific IgE Allergens, and HYTEC Multiple Real-Time PCR Kit.